» Articles » PMID: 29130882

Simultaneous Enumeration of Cancer and Immune Cell Types from Bulk Tumor Gene Expression Data

Overview
Journal Elife
Specialty Biology
Date 2017 Nov 14
PMID 29130882
Citations 696
Authors
Affiliations
Soon will be listed here.
Abstract

Immune cells infiltrating tumors can have important impact on tumor progression and response to therapy. We present an efficient algorithm to simultaneously estimate the fraction of cancer and immune cell types from bulk tumor gene expression data. Our method integrates novel gene expression profiles from each major non-malignant cell type found in tumors, renormalization based on cell-type-specific mRNA content, and the ability to consider uncharacterized and possibly highly variable cell types. Feasibility is demonstrated by validation with flow cytometry, immunohistochemistry and single-cell RNA-Seq analyses of human melanoma and colorectal tumor specimens. Altogether, our work not only improves accuracy but also broadens the scope of absolute cell fraction predictions from tumor gene expression data, and provides a unique novel experimental benchmark for immunogenomics analyses in cancer research (http://epic.gfellerlab.org).

Citing Articles

Molecular subtyping of stage I lung adenocarcinoma via molecular alterations in pre-invasive lesion progression.

Shang J, Jiang H, Zhao Y, Yang J, Lin Y, Zhang N J Transl Med. 2025; 23(1):263.

PMID: 40038757 PMC: 11877874. DOI: 10.1186/s12967-025-06316-6.


Comprehensive molecular portrait reveals genetic diversity and distinct molecular subtypes of small intestinal neuroendocrine tumors.

Patte C, Pommier R, Ferrari A, Chung F, Ouzounova M, Moulle P Nat Commun. 2025; 16(1):2197.

PMID: 40038310 PMC: 11880452. DOI: 10.1038/s41467-025-57305-8.


Hypomethylation of isoform A correlates with transcriptional expression and is associated with poor survival in acute myeloid leukemia.

Wu D, Qiu H, Xu J, Lin J, Qian J Front Immunol. 2025; 16:1490330.

PMID: 40034691 PMC: 11873079. DOI: 10.3389/fimmu.2025.1490330.


Integrative analysis of m7G methylation-associated genes prognostic signature with immunotherapy and identification of LARP1 as a key oncogene in head and neck squamous cell carcinoma.

Xu J, You Z, Zhu Z, Liu M, Zhang Z, Xu P Front Immunol. 2025; 16:1520070.

PMID: 40018039 PMC: 11864954. DOI: 10.3389/fimmu.2025.1520070.


A novel stemness-related lncRNA signature predicts prognosis, immune infiltration and drug sensitivity of clear cell renal cell carcinoma.

Liu J, Yao L, Yang Y, Ma J, You R, Yu Z J Transl Med. 2025; 23(1):238.

PMID: 40016772 PMC: 11869577. DOI: 10.1186/s12967-025-06251-6.


References
1.
Finak G, McDavid A, Yajima M, Deng J, Gersuk V, Shalek A . MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data. Genome Biol. 2015; 16:278. PMC: 4676162. DOI: 10.1186/s13059-015-0844-5. View

2.
Stegle O, Teichmann S, Marioni J . Computational and analytical challenges in single-cell transcriptomics. Nat Rev Genet. 2015; 16(3):133-45. DOI: 10.1038/nrg3833. View

3.
Balch C, Riley L, Bae Y, Salmeron M, Platsoucas C, von Eschenbach A . Patterns of human tumor-infiltrating lymphocytes in 120 human cancers. Arch Surg. 1990; 125(2):200-5. DOI: 10.1001/archsurg.1990.01410140078012. View

4.
Anghel C, Quon G, Haider S, Nguyen F, Deshwar A, Morris Q . ISOpureR: an R implementation of a computational purification algorithm of mixed tumour profiles. BMC Bioinformatics. 2015; 16:156. PMC: 4429941. DOI: 10.1186/s12859-015-0597-x. View

5.
Becht E, Giraldo N, Lacroix L, Buttard B, Elarouci N, Petitprez F . Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016; 17(1):218. PMC: 5073889. DOI: 10.1186/s13059-016-1070-5. View